U.S. Communications Stock News

Investors may be wondering whether Goosehead Insurance at around US$42.44 is starting to look interesting or remains expensive for the level of risk involved. The stock has been volatile recently, delivering a 3.3% return over the last 7 days after declines of 16.5% over 30 days and 39.5% year to date. These moves contribute to a 60.6% return over the past year and 55.3% over five years. Recent coverage has focused on Goosehead Insurance's share price performance and how investors are...

Cirrus Logic (NasdaqGS:CRUS) has combined its Chief Financial Officer and Principal Accounting Officer roles under CFO Jeff Woolard. Former Principal Accounting Officer Ulf Habermann will stay in a senior finance role at the company. The company indicated the leadership change was not the result of any disagreements and framed it as a finance leadership consolidation. Cirrus Logic designs and supplies mixed-signal and audio semiconductors, with its technology used in a range of consumer and...

DocuSign recently announced a new integration that brings its Intelligent Agreement Management platform directly into Slackbot, allowing teams to generate, review, and execute contracts from within Slack using real-time data from systems like Salesforce, while also rolling out an AI-powered contract review assistant built on its Iris engine to streamline legal workflows. Together, these launches show DocuSign pushing beyond basic e-signatures toward AI-driven, agent-assisted agreement...

The Allstate Corporation recently reported estimated catastrophe losses of about US$249 million after tax for January and February 2026, while growing total policies in force 2.5% year over year to 38.4 million, mainly in auto and homeowners coverage. At the same time, Allstate’s mobile app tied for top ranking in an industry scorecard and analysts are anticipating significantly higher first-quarter 2026 earnings compared with a year earlier. We’ll now examine how Allstate’s policy growth...

Key recent performance signals PACS Group (PACS) has drawn investor attention after a mixed stretch in the stock, with a 1 day gain of about 1.5% and a roughly 5% move over the past week, in contrast with weaker returns over the past month and past 3 months. See our latest analysis for PACS Group. At a share price of $32.14, PACS Group’s recent 1 day and 7 day share price gains sit against weaker 1 month and year to date share price returns. The very large 1 year total shareholder return...

In March 2026, APA Corporation participated in the 5th Annual Connected Worker: Energy Summit in Houston, where Director of IT Applications Lisa Cruz highlighted the company’s approach to digital tools for its workforce. At the same time, APA’s fundamentals faced renewed market scrutiny as shifting oil prices and analyst caution refocused attention on how resilient its cash flows really are. We’ll now examine how this oil-price-driven reassessment of APA’s cash flow resilience influences the...

International Paper (NYSE:IP) is contending with operational headwinds tied to cyclical demand weakness, restructuring costs, and plant closures. The company is undergoing leadership turnover, including the recent departure of Joy Roman after a short tenure. Key executives have received incentive awards during this period of corporate transition. J.P. Morgan has placed International Paper on Negative Catalyst Watch, and analysts have reduced earnings estimates, citing cost pressures and...

Setting the scene for Globus Medical Globus Medical (GMED) has been drawing fresh attention after recent share price moves, with the stock last closing at US$87.92 and showing mixed returns over the past month and past 3 months. See our latest analysis for Globus Medical. That recent 4.9% 7 day share price return sits against a flatter 30 day move, while a 27.7% 1 year total shareholder return points to momentum that has built over a longer stretch. If Globus Medical’s move has you thinking...

Johnson & Johnson (NYSE: JNJ) has agreed to an exclusive distribution and promotion deal with KYORIN Pharmaceutical for SIRTURO (Bedaquiline) in Japan. The company is also pursuing a label expansion for SIRTURO to treat Mycobacterium avium complex lung disease, extending its reach beyond multidrug resistant tuberculosis. The arrangement gives Johnson & Johnson a dedicated commercial channel for infectious disease therapies in an important market for new drug launches. For investors watching...

AT&T (NYSE:T) has partnered with Assurant on a "Tree for Trade-In" program that supports reforestation in wildfire affected areas of California. The company has also expanded its fiber presence through the acquisition of Lumen Technologies' fiber assets. These moves highlight fresh developments in both AT&T's environmental initiatives and its core connectivity business. AT&T runs a large U.S. telecom and broadband network, so both network reach and public perception matter for long term...

Investors may be wondering whether Chemed at around US$380.60 is starting to look attractively priced, or if the risk still outweighs the potential reward. The stock has moved 3.3% over the last week, after a 7.7% decline over 30 days and a 10.2% decline year to date, with a 36.0% decline over the past year and 29.9% and 16.8% declines over three and five years respectively. These price moves sit against a backdrop of ongoing coverage of Chemed as a healthcare name on the NYSE, with...

When inflation stories keep circling around energy, food and shipping costs, it can help to focus on something more tangible: the people actually running the businesses you own. Founder-led companies often have leaders with significant personal capital at risk and a long-term mindset that is not tied to quarterly bonus targets. This article looks at how that approach can matter as bond yields move, input costs shift and policy headlines swing. It then highlights 3 standouts from a Top...

Irenic Capital and Randian Capital have launched public activist campaigns urging Snap (NYSE:SNAP) to overhaul its board, operations, and business structure. The investors are calling for actions such as a potential Spectacles spinoff, AI driven operational changes, board refreshment, and more direct engagement with shareholders through town halls. At the same time, Snap faces heightened legal and regulatory pressure, including a formal European Union investigation into youth safety...

In late March 2026, Arm Holdings announced its first in-house Arm AGI CPU for AI data centers and IBM later revealed a collaboration with Arm to develop dual-architecture hardware aimed at enhancing virtualization, security, and performance for enterprise AI and data-intensive workloads. Together, these moves signal Arm’s shift from a pure IP licensing model toward supplying AI-focused silicon and deeper enterprise platform integration, potentially altering how hyperscalers and large...

In March 2026, Intuit was added to the NASDAQ Internet Index and reported Q2 fiscal 2026 results that exceeded management and analyst expectations, prompting several research firms to reiterate positive views on the company while trimming longer-term assumptions. The news highlights how concerns about AI-driven disruption are being weighed against Intuit’s partnerships with leading AI firms and its strong recent execution, shaping how analysts and investors assess its longer-term...

Event overview and recent stock performance Assurant (AIZ) is back on investors’ radar after recent price swings, with the stock now around $218.26 as short term gains in the past week contrast with weaker performance over the past 3 months. See our latest analysis for Assurant. Recent trading has been choppy, with a 2.33% 7 day share price return and an 8.19% year to date share price decline. At the same time, the 1 year total shareholder return of 18.54% and 3 year total shareholder return...

AI power deal and governance move put Babcock & Wilcox Enterprises (BW) in the spotlight Babcock & Wilcox Enterprises (BW) is back on investors’ radar after signing a reported $2.4b agreement to supply power for AI factory campuses, along with a move to declassify its board of directors. See our latest analysis for Babcock & Wilcox Enterprises. The recent jump in investor interest comes on top of strong momentum, with a 1 month share price return of 18.28% and a 90 day share price return of...

Recent performance and context for Alaska Air Group With no single headline event driving attention, Alaska Air Group (ALK) is drawing interest as investors weigh recent share performance against the company’s current fundamentals, including revenue, earnings, and its mix of airline segments. See our latest analysis for Alaska Air Group. At a share price of $37.33, Alaska Air Group has seen a 3.24% 7 day share price return but a 27.54% year to date share price decline, while the 1 year total...

Geron Corporation recently expanded its Board of Directors by appointing Patricia S. Andrews and Constantine Chinoporos, both experienced leaders in oncology commercialization and biopharma deal-making. The addition of directors with deep oncology launch and business development backgrounds may be particularly relevant as Geron progresses RYTELO and evaluates future growth options. Next, we’ll explore how Geron’s addition of seasoned oncology and business development leaders could influence...

Harmony Biosciences recently appointed industry veteran Peter Anastasiou as Senior Executive Vice President and Chief Operating Officer, while reshaping its board with the addition of finance specialist Troy Ignelzi and the nomination of long-time pharmaceutical leader Geno J. Germano for election at the 2026 Annual Meeting. By shifting Anastasiou from the board into an operational role and adding Ignelzi’s capital markets expertise, the company is tightening the link between governance,...

If you are wondering whether Genpact at around US$37.74 is a bargain or a value trap, the key is to understand what the current price actually reflects. The stock has moved 3.2% over the past week, while sitting on a 9.5% decline over 30 days and an 18.5% fall over the last year. These moves can change how the market views both its growth potential and risk profile. Recent coverage has focused on Genpact's positioning within professional services and how its business mix fits with longer...

In recent days, Roblox has drawn fresh attention as analysts revisited their views on the business after updated earnings expectations and engagement trends, while the market reacted to shifting sentiment around the company’s growth and profitability outlook. Despite concerns over age-verification headwinds, Russia-related engagement pressure, and heavier capital spending, many analysts still highlight Roblox’s small share of the global gaming market and growing older user base as central...

Indivior Pharmaceuticals (INDV) is back in focus after a new peer reviewed cost impact model suggested its monthly SUBLOCADE injection could reduce staff time and operational costs for treating opioid use disorder in correctional facilities. See our latest analysis for Indivior Pharmaceuticals. The new cost impact data lands after a volatile stretch for the stock, with the share price at US$30.47 and a 1 year total shareholder return of 224.84% alongside a 74.61% 3 year total shareholder...

ASA Gold and Precious Metals Limited recently declared a US$0.04 per-share distribution, payable on May 13, 2026, up US$0.01 from last year, and extended its investment advisory agreement with Merk Investments LLC for 90 days starting April 1, 2026. The simultaneous distribution increase, special committee review supported by Cantor Fitzgerald, and recognition for earnings strength highlight an actively evolving story around ASA’s capital return and governance approach. Next, we examine how...